Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease
Status:
Active, not recruiting
Trial end date:
2021-12-10
Target enrollment:
Participant gender:
Summary
This study proposes to evaluate clinical outcomes and viral load in COVID-19 infected
patients with early moderate and severe disease admitted to the hospital and randomized to
one of three arms. Patients will be randomized to supportive care, OR hydroxychloroquine
alone, OR hydroxychloroquine and azithromycin.